Skip to main content

Advertisement

Table 1 Table 1

From: Infliximab in the treatment of refractory uveitis. Does dose really matter?

  LD MD HD
Anatomic classification of Uveitis among cohort (%)    
Anterior Uveitis 100 31 33
Intermediate Uveitis 0 <1 1
Posterior Uveitis 0 26 33
Panuveitis 0 42 44
Mean age at diagnosis of uveitis (yrs) 8.9 8.4 8.5
Mean age of onset of treatment (yrs) 10.8 10.9 12.1
Mean duration of other medication regimens prior to infliximab (yrs) 2.0 2.6 3.5
Duration of treatment with topical steroids prior to infliximab (mo) 10.6 12.3 15.4
Time to discontinuation of steroids after infliximab (mo) 3.1 9.5 10.2
Patients requiring dose escalation (%) 67 35 55
Average time to dose escalation (mo) 5.1 7.5 14